Objective: To evaluate the postoperative outcome of multiple slit on plaque plication technique for the treatment of Peyronie Je Jong Ki. Methods: We retrospectively evaluated 22 patients who underwent plaque incision with penile plication for surgical treatment of Peyronieu Geon Moon of tamoxifen, L-l treatment between 2009 and 2014. Patients were grouped by pre-operative degree of penile curvature such as Group I: mild [n=5 (22%)], Group II: moderate [n=11 (50%)], and Group III: severe [n=6 (27%)]. On the thorough review of medical records, we evaluated (I) correction of the curvature; (II) sexual function; and (III) any penile shortening or other complications. Results: The mean postoperative follow-up period was 39 months. Complete correction of the curvature was obtained in 21 patients (95%). As inevitable complication, minimal penile shortening (<1.5 cm) was reported by 14 patients (82%) but did not adversely affect sexual intercourse (0%) and all patients accepted for penile shortening. And 19 patients had good erectile function [International Index of Erectile Function (IIEF)5 >21]. The most frequent complication was the subcutaneous penile edema in three patients (13.6%), which was resolved within about 3 months after surgery. Conclusions: As modified technique, multiple slit on plaque with plication is a simple, non-invasive and effective technique for correcting penile curvature regardless of curvature severity. And the degree of penile curvature does not significantly predict the amount of penile length loss.
AB083. Does concomitant testosterone replacement improve the response of tadalafil 5 mg once daily in men with lower urinary tract symptoms?
Objectives: Recently, tadalafil was found to be effective for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) . Testosterone (T) regulates nitric oxide synthase and is necessary to achieve an optimum response to PDE5 inhibitors. In the present study, we determined whether T replacement in men with low T levels receiving tadalafil to treat LUTS improved the response of tadalafil on LUTS. Methods: The present 12-week study was a randomized parallel study of clinical outcomes in men aged ≥40 years with symptomatic BPH (IPSS ≥12), prostate volumes ≥30 mL, and testosterone levels less than 300 ng/dl. Eligible patients received a combination of tadalafil 5 mg once daily and placement of a transdermal gel containing 10 g T (n=44), or tadalafil alone (n=46). The primary outcomes were posttreatment IPSS, peak urinary flow rate, and post-void residual urine volume (PVR). Secondary outcomes were changes in IIEF-EF domain scores, Global Assessment Questionnaire (GAQ) scores, and Life Satisfaction Checklist (LSC) scores. Results: The extent of IPSS improvement from baseline to 12 weeks was the same in both groups (tadalafil+T -5.2 vs. tadalafil -5.0; P=0.634). Also, the changes in Q(max) and PVR from baseline were very similar in both groups. However, the tadalafil+T group showed a significantly greater change from baseline in the IPSS storage subscore, the IPSS-QoL score, and the IIEF-EF domain score. The tadalafil+T group showed significantly greater improvements in GAQ and LSC scores, as compared to the tadalafil-only group. The adverse event profiles of each group were similar to those of previous reports. Conclusions: Tadalafil plus testosterone was superior to tadalafil alone in improving LUTS in men with BPH/ LUTS and low testosterone levels. Further study is needed with more number of patients and longer duration study for support of present study. Objective: Infertility is defined as the failure to achieve clinical pregnancy after twelve months of regular unprotected sexual intercourse. In recent years, there is a rising trend of infertility in China, data shows that every eight couples have a pair of infertility, and the number of Chinese infertility patients has more than 50 million. Female infertility has various negative impacts on quality of life. In the past, various generic measurement tools were used for assessing Qol in infertile patients. Recently, a specifically Qol tool designed for infertile couples, has been developed and used internationally-The Fertility Quality of life(FertiQol)-questionaire. To the best of our knowledge, there was no published data regarding the general Qol in women in mainland china. Our goal of this study is to understand the preliminary level of Qol in infertile women in mainland china, secondary aims was to compare Qol in women with primary and secondary infertility. Methods: The FertiQol tool, a self-report questionnaire, was distributed to our department of Reproductive Center for infertile women who undergoing the treatment of in vitro fertilization from 2015.1 to 2015.4. Patients with primary and secondary infertility were compared for Qol subscales, and other confounding factors were investigated using multiple regression analysis. Results: A total of 230 copies of eligible FertiQol questionnaires were collected, among them, 162 cases for primary infertility and 68 cases for Secondary infertility. The mean age of participants was 32.6±3.3 years and years of marriage was 4.2±1.3. Scores of mind-body (55.4), relational (57.4), environment (54.0), and tolerability (45.0) subscales in Chinese infertile women were lower than those (54.8, 68.7, 61.5 and 58.8) in western infertile women. According to the increase of infertility time, relational score (relation with husband) was decreased. Women with secondary infertility obtained higher scores in emotional, mind/body of the core subscale, and tolerability of the treatment subscale (P<0.05). Multiple regression analysis showed that the status of educational and secondary infertility had a positive impact. Conclusions: FertiQol scores were better in patients with secondary infertility and higher educational status. This is the first validation study of mainland Chinese FertiQoL, and potentially used as a guide for clinical counseling and future works. 
